Extensive research is underway on how to use microbiome therapy to prevent and treat intractable digestive diseases, including inflammatory bowel disease. In this session, we have prepared an unprecedented lecture that will provide insight into how the microbiome, also called the hidden organ, interacts with the host and the importance of the gut barrier in IBD patients. In addition, FMT, which is being used in various field as a treatment modality using the microbiome, will be highlighted and deep insight into future research directions will be discussed. The attention devoted to the microbiome will be presented by world-famous researchers. Dive into this session together for practical insights into the mechanism of IBD!

With the increasing importance of environmental factors as one pathogenesis in various diseases, recently, many clinicians have paid more attention to diet and nutrition as triggers or treatment of intestinal disease. In this session, we will discuss the role of diet therapy in adults as well as children with IBD by introducing a specific diet and multidisciplinary approach. In addition, we will also explore the contribution of diet and nutrition to colorectal cancer development and clinical outcomes based on the latest knowledge.

- Prize: USD 200
- Number of winners: 50 Awardees
- Eligibility

• Pre-registration by March 31 (Sun.), 2024 is required.
• Participants of foreign affiliations who are not presenting authors can be candidates for the travel grants. Specifically, foreign participants who did not submit abstracts OR who are corresponding authors or co-authors are eligible.
• Participants from countries listed on the have priority, however, this qualification is only a priority, not mandatory.

IMKASID 2024 Pre-Registration is ongoing! We implore you to register now to take advantage of pre-registration rates and then join the IMKASID 2024!
Some sessions require pre-registration, so don't miss this opportunity.